Phloretin-induced apoptosis in B16 melanoma 4A5 cells by inhibition of glucose transmembrane transport

Cancer Letters

Volumn 119, Issue 2, 1997, Pages 207-212

  Kobori, Masuko ^a   Shinmoto, Hiroshi ^a   Tsushida, Tojiro ^a   Shinohara, Kazuki ^a,b  

^a NATIONAL FOOD RESEARCH INSTITUTE   (Japan)

^b FISHERIES RESEARCH AGENCY   (Japan)

Author keywords

Apoptosis; Glucose transport; Melanoma cells; Phloretin; Protein kinase C

Indexed keywords

DNA FRAGMENT; GLUCOSE TRANSPORTER; PHLORETIN; PROTEIN KINASE C;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GLUCOSE TRANSPORT; MELANOMA B16; MELANOMA CELL; MOUSE; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELL MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; MELANOMA, EXPERIMENTAL; MICE; PHLORETIN; PROTEIN KINASE C;

ANIMALIA;

EID: 0030662604     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00271-1     Document Type: Article

References (23)

1. D.W. Salter, S. Custead-Jones, J.S. Cook, Quercetin inhibits hexose transport in a human diploid fibroblast, J. Membr. Biol. 40 (1978) 67-76.
2. M. Gschwendt, F. Horn, W. Kittstein, G. Furstenberger, E. Besenfelder, F. Marks, Calcium and phospholipid-dependent protein kinase activity in mouse epidermis cytosol. Stimulation by complete and incomplete tumor promoters and inhibition by various compounds, Biochem. Biophys. Res. Commun. 124 (1984) 63-68.
3. R.J. Miksicek, Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor, J. Steroid Biochem. Mol. Biol. 49 (1994) 153-160.
4. M.A. Devi, N.P. Das, In vitro effects of natural plant polyphenols on the proliferation of normal and abnormal human lymphocytes and their secretions of interleukin-2, Cancer Lett. 69 (1993) 191-196.
5. J.A.S. Nelson, R.E. Falk, The efficacy of phloridzin and phloretin on tumor cell growth, Anticancer Res. 13 (1993) 2287-2292.
6. R. Bertrand, E. Solary, J. Jenkins, Y. Pommier, Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors, Exp. Cell Res. 207 (1993) 388-397.
7. D.E. Macfarlane, P.S. O'Donnel, Phorbol ester induces apoptosis in HL-60 promyelocytic leukemia cells but not in HL-60 PET mutant, Leukemia 7 (1993) 1846-1851.
8. W.D. Jarvis, A.J. Turner, L.F. Povirk, R.S. Traylor, S. Grant, Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C, Cancer Res. 54 (1994) 1707-1714.
9. W. Gorczyca, J. Gong, B. Ardelt, F. Traganos, Z. Darzynkiewicz, The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents, Cancer Res. 53 (1993) 3186-3192.
10. Y. Wei, X. Zhao, Y. Kariya, H. Fukata, K. Teshigawara, A. Uchida, Induction of apoptosis by quercetin: involvement of heat shock protein, Cancer Res. 54 (1994) 4952-4957.
11. M.J. McCabe Jr., S. Orrenius, Genistein induces apoptosis in immature human thymocytes by inhibiting topoisomerase-II, Biochem. Biophys. Res. Commun. 194 (1993) 944-950.
12. O. Kan, S.A. Baldwin, A.D. Whetton, Apoptosis is regulated by the rate of glucose transport in a interleukin 3 dependent cell line, J. Exp. Med. 180 (1994) 917-923.
13. G.A. Blobel, S.H. Orkin, Estrogen-induced apoptosis by inhibition of the erythroid transcription factor GATA-1, Mol. Cell. Biol. 16 (1996) 1687-1694.
14. E. Falcieri, A.M. Martelli, R. Bareggi, A. Cataldi, L. Cocco, The protein kinase inhibitor staurosporine induces morphological changes typical of apoptosis in Mort-4 cells without concomitant DNA fragmentation, Biochem. Biophys. Res. Commun. 193 (1993) 19-25.
15. R. Bertrand, E. Solary, P. O'Connor, K.W. Kohn, Y. Pommier, Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors, Exp. Cell Res. 211 (1994) 314-321.
16. 2-induced apoptosis of cultured B16 melanoma cell line through down-regulation of PKC activity, Biochem. Biophys. Res. Commun. 219 (1996) 480-485.
17. R.M. Krupka, Asymmetrical binding of phloretin to the glucose transport system of human erythrocytes, J. Membr. Biol. 83 (1985) 71-80.
18. A.L. Betz, L.R. Drewes, D.D. Gilboe, Inhibition of glucose transport into brain by phlorizin, phloretin and glucose analogues, Biochim. Biophys. Acta 406 (1975) 505-515.
19. B.M. Sahagian, Active glucose uptake by strips of guinea pig intestine; competitive inhibition by phlorizin and phloretin, Can. J. Biochem. 43 (1965) 851-858.
20. J.A.S. Nelson, R.E. Falk, The efficacy of phloridzin and phloretin on tumor cell growth, Anticancer Res. 13 (1993) 2293-2300.
21. A. Constantinous, R. Mehta, C. Runya, K. Rao, A. Vaughan, R. Moon, Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships, J. Nat. Prod. 58 (1995) 217-225.
22. D.S. Grove, A.M. Mastro, Prevention of the TPA-mediated down-regulation of protein kinase C, Biochem. Biophys. Res. Commun. 151 (1988) 94-99.
23. T. Akiyama, J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, N. Itoh, M. Shibuya, Y. Fukami, Genistein, a specific inhibitor of tyrosine-specific protein kinases, J. Biol. Chem. 262 (1987) 5592-5595.